Seattle Genetics (SGEN) Commences Tender Offer for Cascadian Therapeutics (CASC)
February 8, 2018 5:43 PM
Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that its wholly-owned subsidiary, Valley Acquisition Sub, Inc., has commenced its previously announced ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)